Refine by
Heart Attack Articles & Analysis
90 news found
“Some of the health effects listed by the department due to lead exposure include decreased brain and kidney function, raised blood pressure, increased chances of having a heart attack or stroke, and for pregnant individuals, increased chances of a miscarriage and harm to a baby’s development before birth,” said Frank Selamie, President of CTSI. ...
Furthermore, Semaglutide has demonstrated the ability to reduce the risk of cardiovascular events, such as heart attacks and strokes, in individuals with type 2 diabetes and established cardiovascular disease. ...
Mitochondria dysfunction has been tied to a host of diseases, ranging from neurodegenerative ailments, over heart attacks and strokes, to age-related degeneration. "Whilst Mitochondria have been known as disease targets for a long time, treating them has proven challenging", notes Dr. ...
Revacept proved to be particularly effective when stroke, bleeding and heart attack were considered together. Here, the novel active ingredient in the dosage of 120 milligrams caused a significant reduction of more than 54 percent compared to those treated with placebo. ...
The company also plans other clinical studies in additional cardiovascular indications, including heart failure caused by ischemic heart disease and as adjunctive therapy to percutaneous coronary intervention. ...
If left untreated, this can lead to serious complications such as heart attack, stroke, obesity, eye disease, kidney disease and nerve damage. ...
” The product labels of all JAK inhibitors will be updated to include a precautionary approach for patients aged 65 years or above, those at increased risk of major cardiovascular problems (such as heart attack or stroke), those who smoke or have done so for a long time in the past and those at increased risk of cancer. ...
Elucid has developed FDA-cleared Plaque Analysis and investigational FFRCT tools designed to enable physicians to diagnose and understand the direct cause of myocardial ischemia, while also identifying coronary plaque that is at highest risk to rupture and result in a heart attack. “Elucid has developed a plaque analysis software based on ground truth ...
ByElucid
Advanced clinical insights from Elucid equip physicians with critical information designed to enable precision medicine for both assessing the risk of plaque rupture in arteries that can lead to heart attack and stroke, as well as assessing blockages to determine the need for revascularization. ...
ByElucid
Robert Hancock at The University of British Columbia, is raising awareness about sepsis: a serious medical condition that is the body’s overwhelming and life-threatening response to infection that can lead to tissue damage, organ failure, and death. It more common than heart attack and claims more lives than any cancer but is often misdiagnosed. ...
The company is developing a novel rapid diagnostic test that will enable healthcare professionals to provide earlier and more targeted treatment of sepsis – a global healthcare problem that is more common than heart attack and claims more lives than any cancer. Infectious disease testing (including sepsis) is one of the fastest growing molecular diagnostic ...
“These messages include DNA, RNA, protein and lipid biomarkers found in blood (or other biofluids) that have important applications in research, diagnosis and treatment for cancer, as well as cardiometabolic diseases like heart attack and diabetes, inflammatory diseases such as rheumatoid arthritis and Crohn’s disease, and neurodegenerative diseases ...
About the FXIa Clinical Trial Program The PACIFIC Phase IIb clinical trial program consisted of three Phase IIb studies, each one focusing on one of the following medical conditions: atrial fibrillation (irregular heartbeat), a recent non-cardioembolic ischemic stroke or a recent acute myocardial infarction (heart attack). The PACIFIC clinical trials comprised ...
ByBayer AG
“I am convinced that Elucid’s pioneering computed tomography-based technology will fundamentally shift how we treat and prevent heart disease. The company’s technology helps physicians fl ag the patients who are truly at risk for heart attacks and stroke and directs a patient-specific treatment pathway. ...
ByElucid
This year, the honor went to researchers at Hannover School of Medicine who demonstrated that 68Ga-FAPI-46 PET, when correlated with cardiac MRI, is a new specific indicator of active fibrosis and can identify a patient’s chance of recovery following a heart attack. The depiction of 68Ga-FAPI-46 PET signal after acute anterior myocardial infarction was ...
BySOFIE
Severe peripheral vascular disease (PVD) is caused by the formation of blockages in arteries, which reduces blood supply to the brain, heart, kidneys and limbs causing strokes, heart attacks, kidney failure and limb amputations. ...
XC001 is designed to promote new blood vessels in the heart that will bypass diseased blood vessels and improve blood flow. ...
Specifically, the exquisite algorithms developed through machine learning characterize tissue types in the artery wall known to cause heart attacks, such as lipid rich necrotic core. The capability to discern complex plaque biology at the cellular and molecular level is powering new applications that can derive fractional flow reserve (FFRct), risk of ...
ByElucid
The primary efficacy endpoint was a composite of MALE and MACE, ie. acute limb ischemia, major amputation of a vascular etiology, heart attack (myocardial infarction, MI), ischemic stroke or cardiovascular death. ...
ByBayer AG
He suffered severe diarrhea and multiple heart attacks until, one by one, his organs began to shut down. Eleven days after being mistakenly diagnosed with the flu, Augustin Peña died of a little-known illness called sepsis. ...